ATF4 alleviates doxorubicin-induced cardiomyopathy through H2S-mediated antioxidation
Shuting Xu, Yan Shi, Xiaoshuai Zhao, Xuhui Chen, Ying Liu, Fan Zhang, Fangchi Yu, Linhao Ruan, Chaolong Wang, Xuejun Jiang, Xiaoding Wang, Guangyu Zhang
This study shows ATF4 protects against doxorubicin-induced cardiomyopathy by enhancing H2S-mediated antioxidation through upregulation of CSE.
bioRxiv · Sep 3, 2025 · PreprintPathology